Literature Review of COVID-19 Antivirus Activities Bioactive Compounds and Herbal Plant Extracts

Authors

  • Yulianis Yulianis Pharmacy Study Program, STIKES Harapan Ibu, Jambi, Indonesia, Indonesia
  • Rizky Yulion Putra Pharmacy Study Program, STIKES Harapan Ibu, Jambi, Indonesia, Indonesia
  • Nadiva Putri Agustina Pharmacy Study Program, STIKES Harapan Ibu, Jambi, Indonesia, Indonesia

DOI:

https://doi.org/10.54543/kesans.v2i12.227

Keywords:

COVID-19, Antiviral, Herbal Plant, Bioactive, Extract

Abstract

Introduction: Currently the world is being hit by a virus outbreak that causes symptoms of pneumonia, on December 31, 2019 China reported a mysterious case of pneumonia with no known cause. Objective: The purpose of this study was to look at bioactive compounds and extracts that have the potential as COVID-19 antivirals. Method: This research is a literature study derived from the PubMed and Science Direct databases using the Preparred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) method. Result and Discussion: In the results of the literature review, 22 articles were found that entered the inclusion criteria. The average extracts and compounds in pre-clinical data showed a very strong IC50 value with a value of <50 ug/ml, while in clinical trials, herbal plant products showed that they were anti-inflammatory and immunomodulatory. Conclusion: So, it can be concluded that natural product products from herbal plants have the potential as an antiviral for COVID-19

Downloads

Published

2023-09-20

How to Cite

Yulianis, Y., Yulion Putra, R., & Putri Agustina, N. (2023). Literature Review of COVID-19 Antivirus Activities Bioactive Compounds and Herbal Plant Extracts. KESANS : International Journal of Health and Science, 2(12), 1029–1045. https://doi.org/10.54543/kesans.v2i12.227

Citation Check

Similar Articles

1 2 3 4 > >> 

You may also start an advanced similarity search for this article.